There is compelling, indirect evidence of hepatic deficiency due primarily to the respective genetic errors of the three inducible hepatic porphyrias, acute intermittent porphyria, porphyria variegata, and hereditary corproporphyria. The induction is enhanced by exogenous inducers such as barbiturate, estrogens, and other 'porphyrogenic' chemicals and factors, including glucose deprivation. The newer knowledge of the induction of δ-aminolevulinic acid synthetase [δ-aminolevulinate synthase; succinyl-CoA:glycine C-succinyl-transferase (decarboxylating), EC 184.108.40.206] in relation to inadequate heme, and repression by heme, stimulated early trials of hematin infusions to overcome the acute relapse in the foregoing inducible porphyrias. Recently this experience has been considerably expanded, 143 infusions of hematin having been given in 22 cases. Studies of the effect on the serum concentrations of δ-aminolevulinic acid and porphobilinogen have shown a highly significant decline, often to O, especially of δ-aminolevulinic acid. A distinct relationship to the clinical severity of the attack has been evident in the frequency and magnitude of decline of serum δ-aminolevulinic acid and porphobilinogen. This was regularly associated with objective clinical improvement.
|Original language||English (US)|
|Number of pages||3|
|Journal||Proceedings of the National Academy of Sciences of the United States of America|
|State||Published - 1977|